Clinical differences between North African and Iraqi Jews with familial Mediterranean fever

Area of Science:

• Genetics
• Immunology
• Rheumatology

Background:

• Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterized by recurrent episodes of fever and serositis.
• The genetic basis of FMF lies in mutations within the MEFV gene, located on chromosome 16p.
• FMF prevalence is notably high in specific populations, including North African and Iraqi Jews in Israel.

Purpose of the Study:

• To investigate and compare the clinical severity of Familial Mediterranean fever (FMF) between North African Jewish and Iraqi Jewish populations.
• To identify potential factors contributing to observed variations in disease presentation and progression.

Main Methods:

• Retrospective analysis of clinical data from FMF patients of North African and Iraqi Jewish descent.
• Comparison of disease parameters including age of onset, frequency and severity of joint involvement, erysipelas-like erythema incidence, and colchicine dosage requirements.

Main Results:

• North African Jews exhibited a more severe FMF phenotype compared to Iraqi Jews.
• Key differences included an earlier age of onset, increased joint involvement, higher incidence of erysipelas-like erythema, and greater colchicine requirement in the North African group.
• These findings highlight significant clinical heterogeneity within the FMF patient population.

Conclusions:

• Clinical severity of FMF varies between North African and Iraqi Jewish populations.
• Factors such as additional genetic modifiers, environmental influences, or distinct MEFV mutation profiles likely contribute to this observed clinical variation.
• Further research is warranted to elucidate the specific mechanisms underlying these differences in disease severity.